Psychedelic-assisted therapy: An overview for the internist.

Address: Department of Psychiatry and Psychology, Cleveland Clinic, Cleveland, OH; Assistant Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH; Principal investigator, Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRD NCT05711940, and A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (VOYAGE) NCT06741228 [email protected].; Researcher, Center for Neurointestinal Health, Massachusetts General Hospital Division of Gastroenterology, Boston, MA; Assistant Professor, Pediatric Gastroenterology, Tufts Medical Center, Boston, MA; Co-investigator, Assessment of Psilocybin (TRP-8802) in Concert With Psychotherapy in Patients With Irritable Bowel Syndrome (IBS) NCT06206265.; Director, Training and Education, Center for Neuroscience of Psychedelics, Massachusetts General Hospital, Boston, MA; Instructor, Department of Psychiatry, Harvard Medical School, Boston, MA; Principal investigator, Assessment of Psilocybin (TRP-8802) in Concert With Psychotherapy in Patients With Irritable Bowel Syndrome (IBS) NCT06206265.